stella
beta
Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery — Stella
Recruiting
Back to Urinary Retention Postoperative trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
United States
Mayo Clinic in Rochester, Rochester, Minnesota
View full record on ClinicalTrials.gov